Sequence variability among different parvovirus B19 isolates

References

1. Anderson M. J., Khousam M. N., Maxwell D. J., Gould S. J., Happerfield L. C., Smith W. J. 1988; Human parvovirus B19 and hydrops fetalis. Lancet i:535.
   [Google Scholar]
2. Brown K. E., Young N. S., Liu J. M. 1994; Molecular, cellular and clinical aspects of parvovirus B19 infection. Critical Reviews in Oncology and Hematology 16:1–31
   [Google Scholar]
3. Cassinotti P., Schultze D., Schlageter P., Chevili S., Siegl G. 1993; Persistent parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. European Journal of Clinical Microbiology and Infectious Diseases 12:701–704
   [Google Scholar]
4. Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Diagnostic assays with monoclonal antibodies for the serum parvovirus-like virus. Journal of Hygiene, London 91:113–130
   [Google Scholar]
5. Doerig C., Beard P., Antonietti J. P., Hirt B. 1990; Nonstructural protein of parvovirus B19 and minute virus of mice controls transcription. Journal of Virology 64:367–396
   [Google Scholar]
6. Foto F., Sang K. G., Scharosch L. L., Howard E. J., Naides S. J. 1993; Parvovirus Bl9-specific DNA in bone marrow from B19 arthopathy patients: evidence for B19 virus persistence. Journal of Infectious Diseases 167:744–748
   [Google Scholar]
7. Frickhofen N., Abkowitz J. L., Safford M., Berry M., Antunez-De-Mayold J., Astrow A., Cohen R., Halperin I., Mintzer D., Bohen B., Young N. S. 1990; Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1). A treatable cause of anaemia in AIDS. Annals of Internal Medicine 113:926–933
   [Google Scholar]
8. Kerr J. R., Curran M. D., Moore J. E., Coyle P. V., Ferguson N. P. 1995; Persistent parvovirus B19 infection. Lancet 345:1118
   [Google Scholar]
9. Kurtzman G. J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N. S. 1987; Chronic bone marrow failure due to persistent B19 parvovirus infection. New England Journal of Medicine 317:287–294
   [Google Scholar]
10. Kurtzman G. J., Cohen B., Field A. M., Oseas R., Blease R. M., Young N. S. 1989; Immune response to B19 parvovirus and an antibody defect in persistent viral infection. Journal of Clinical Investigation 84:1114–1123
    [Google Scholar]
11. Ozawa K., Ayub J., Kajigaya S., Shimada T., Young N. S. 1988; The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. Journal of Virology 62:2884–2889
    [Google Scholar]
12. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White F. M., Stroud C. E., Murtaza L. 1981; Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet i:664–665
    [Google Scholar]
13. Pont J., Puchhammer-Stöckl E., Chott A., Popow-Kraupp T., Kienzer H., Postner G., Honetz N. 1992; Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. British Journal of Haematology 80:160–165
    [Google Scholar]
14. Rosenfeld S. J., Young N. S., Ailing D., Ayub J., Saxinger C. 1994; Subunit interaction in B19 parvovirus empty capsids. Archives of Virology 136:9–18
    [Google Scholar]
15. Saal J. G., Steidle M., Einsele H., Müller C. A., Fritz P., Zacher J. 1992; Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatology International 12:147–151
    [Google Scholar]
16. Saikawa T., Anderson S., Momoeda M., Kajigaya S., Young N. S. 1992; Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique region and VP1-VP2 junction region. Journal of Virology 67:3004–3009
    [Google Scholar]
17. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organisation of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58:921–936
    [Google Scholar]
18. von Poblotzki A., Gigler A., Lang B., Wolf H., Modrow S. 1995a; Antibodies to parvovirus B19 NS-1 protein in infected individuals. Journal of General Virology 76:519–527
    [Google Scholar]
19. von Poblotzki A., Hemauer A., Gigler A., Puchhammer-Stöckl E., Heinz F. X., Pont J., Wolf H., Modrow S. 1995b; Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. Journal of Infectious Diseases 172:1356–1359
    [Google Scholar]
20. Yoshimoto K., Rosenfeld S., Frickhofen N., Kennedy D., Kajigya S., Young N. S. 1991; A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. Journal of Virology 65:7056–7060
    [Google Scholar]
21. Young N. S., Ozawa K. 1988 Studies of B19 virus in bone marrow cell culture. In Parvoviruses and Human Disease pp 117–132 Editor-in-chief Pattison J. R. Boca Raton, FL: CRC Press;
    [Google Scholar]